US Stock MarketDetailed Quotes

BTTX Better Therapeutics

Watchlist

0.009
0.000-3.43%

15min DelayClose Apr 17 16:00 ET

490.64KMarket Cap-8P/E (TTM)

Better Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-51.43%5.34M

-26.82%7.03M

-4.49%8.93M

25.20%38.26M

-31.25%8.32M

22.25%11M

48.27%9.6M

212.86%9.35M

382.70%30.56M

12.1M

Selling and administrative expenses

-36.44%3.51M

-10.69%4.79M

-2.40%5.54M

96.17%21.82M

-8.30%5.27M

137.07%5.52M

273.12%5.36M

252.52%5.67M

316.47%11.12M

--5.75M

-Selling and marketing expense

-10.60%1.39M

1.25%1.7M

2.94%2.1M

198.76%6.98M

44.01%1.7M

182.07%1.56M

198.40%1.68M

4,653.49%2.04M

981.48%2.34M

--1.18M

-General and administrative expense

-46.59%2.12M

-16.16%3.08M

-5.40%3.43M

68.90%14.84M

-21.76%3.58M

123.09%3.96M

321.44%3.68M

131.67%3.63M

257.96%8.79M

--4.57M

Research and development costs

-66.53%1.83M

-47.18%2.24M

-7.73%3.39M

-15.41%16.44M

-52.01%3.05M

-17.85%5.48M

-15.82%4.24M

166.55%3.67M

431.04%19.44M

--6.35M

Operating profit

51.43%-5.34M

26.82%-7.03M

4.49%-8.93M

-25.20%-38.26M

31.25%-8.32M

-22.25%-11M

-48.27%-9.6M

-212.86%-9.35M

-383.31%-30.56M

-12.1M

Net non-operating interest income expense

-27.59%-518K

-71.12%-563K

-35.96%-431K

-705.95%-1.49M

-141.21%-439K

-406K

-32,800.00%-329K

-15,750.00%-317K

-85.00%-185K

-182K

Non-operating interest expense

27.59%518K

71.12%563K

35.96%431K

705.95%1.49M

141.21%439K

--406K

32,800.00%329K

15,750.00%317K

85.00%185K

--182K

Other net income (expense)

-5,255.03%-9.74M

-1.61M

Gain on sale of security

----

-5,597.35%-10.39M

---1.61M

Special income (charges)

----

--0

----

--647K

--0

-Less:Other special charges

----

---647K

--0

Income before tax

48.61%-5.86M

23.57%-7.59M

3.17%-9.36M

1.82%-39.75M

36.96%-8.76M

8.50%-11.4M

-14.79%-9.93M

-76.28%-9.66M

-549.47%-40.49M

-13.9M

Income tax

0.00%3K

104.58%7K

233.33%4K

-200.00%-153K

-3K

Net income

48.60%-5.86M

23.56%-7.59M

3.16%-9.36M

1.43%-39.76M

36.92%-8.77M

8.47%-11.41M

-14.77%-9.93M

-81.28%-9.66M

-531.52%-40.34M

-13.89M

Net income continuous Operations

48.60%-5.86M

23.56%-7.59M

3.16%-9.36M

1.43%-39.76M

36.92%-8.77M

8.47%-11.41M

-14.77%-9.93M

-81.28%-9.66M

-531.52%-40.34M

---13.89M

Minority interest income

Net income attributable to the parent company

48.60%-5.86M

23.56%-7.59M

3.16%-9.36M

1.43%-39.76M

36.92%-8.77M

8.47%-11.41M

-14.77%-9.93M

-81.28%-9.66M

-531.52%-40.34M

-13.89M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

48.60%-5.86M

23.56%-7.59M

3.16%-9.36M

1.43%-39.76M

31.03%-8.77M

11.34%-11.41M

-9.77%-9.93M

-68.98%-9.66M

-410.96%-40.34M

-12.71M

Basic earnings per share

68.75%-0.15

42.86%-0.24

4.88%-0.39

45.66%-1.69

47.89%-0.37

11.94%-0.48

-9.60%-0.42

-69.22%-0.41

-829.76%-3.11

-0.71

Diluted earnings per share

68.75%-0.15

42.86%-0.24

4.88%-0.39

45.66%-1.69

47.89%-0.37

11.94%-0.48

-9.60%-0.42

-69.22%-0.41

-829.76%-3.11

-0.71

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-51.43%5.34M	-26.82%7.03M	-4.49%8.93M	25.20%38.26M	-31.25%8.32M	22.25%11M	48.27%9.6M	212.86%9.35M	382.70%30.56M	12.1M
Selling and administrative expenses	-36.44%3.51M	-10.69%4.79M	-2.40%5.54M	96.17%21.82M	-8.30%5.27M	137.07%5.52M	273.12%5.36M	252.52%5.67M	316.47%11.12M	--5.75M
-Selling and marketing expense	-10.60%1.39M	1.25%1.7M	2.94%2.1M	198.76%6.98M	44.01%1.7M	182.07%1.56M	198.40%1.68M	4,653.49%2.04M	981.48%2.34M	--1.18M
-General and administrative expense	-46.59%2.12M	-16.16%3.08M	-5.40%3.43M	68.90%14.84M	-21.76%3.58M	123.09%3.96M	321.44%3.68M	131.67%3.63M	257.96%8.79M	--4.57M
Research and development costs	-66.53%1.83M	-47.18%2.24M	-7.73%3.39M	-15.41%16.44M	-52.01%3.05M	-17.85%5.48M	-15.82%4.24M	166.55%3.67M	431.04%19.44M	--6.35M
Operating profit	51.43%-5.34M	26.82%-7.03M	4.49%-8.93M	-25.20%-38.26M	31.25%-8.32M	-22.25%-11M	-48.27%-9.6M	-212.86%-9.35M	-383.31%-30.56M	-12.1M
Net non-operating interest income expense	-27.59%-518K	-71.12%-563K	-35.96%-431K	-705.95%-1.49M	-141.21%-439K	-406K	-32,800.00%-329K	-15,750.00%-317K	-85.00%-185K	-182K
Non-operating interest expense	27.59%518K	71.12%563K	35.96%431K	705.95%1.49M	141.21%439K	--406K	32,800.00%329K	15,750.00%317K	85.00%185K	--182K
Other net income (expense)									-5,255.03%-9.74M	-1.61M
Gain on sale of security	----	----	----	----	----	----	----	----	-5,597.35%-10.39M	---1.61M
Special income (charges)	----	----	----	--0	----	----	----	----	--647K	--0
-Less:Other special charges	----	----	----	----	----	----	----	----	---647K	--0
Income before tax	48.61%-5.86M	23.57%-7.59M	3.17%-9.36M	1.82%-39.75M	36.96%-8.76M	8.50%-11.4M	-14.79%-9.93M	-76.28%-9.66M	-549.47%-40.49M	-13.9M
Income tax	0.00%3K	1K	1K	104.58%7K	233.33%4K	3K	0	0	-200.00%-153K	-3K
Net income	48.60%-5.86M	23.56%-7.59M	3.16%-9.36M	1.43%-39.76M	36.92%-8.77M	8.47%-11.41M	-14.77%-9.93M	-81.28%-9.66M	-531.52%-40.34M	-13.89M
Net income continuous Operations	48.60%-5.86M	23.56%-7.59M	3.16%-9.36M	1.43%-39.76M	36.92%-8.77M	8.47%-11.41M	-14.77%-9.93M	-81.28%-9.66M	-531.52%-40.34M	---13.89M
Minority interest income
Net income attributable to the parent company	48.60%-5.86M	23.56%-7.59M	3.16%-9.36M	1.43%-39.76M	36.92%-8.77M	8.47%-11.41M	-14.77%-9.93M	-81.28%-9.66M	-531.52%-40.34M	-13.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	48.60%-5.86M	23.56%-7.59M	3.16%-9.36M	1.43%-39.76M	31.03%-8.77M	11.34%-11.41M	-9.77%-9.93M	-68.98%-9.66M	-410.96%-40.34M	-12.71M
Basic earnings per share	68.75%-0.15	42.86%-0.24	4.88%-0.39	45.66%-1.69	47.89%-0.37	11.94%-0.48	-9.60%-0.42	-69.22%-0.41	-829.76%-3.11	-0.71
Diluted earnings per share	68.75%-0.15	42.86%-0.24	4.88%-0.39	45.66%-1.69	47.89%-0.37	11.94%-0.48	-9.60%-0.42	-69.22%-0.41	-829.76%-3.11	-0.71
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall